DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hsu C-H, Yang T-S, Hsu C , et al.
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.
Br J Cancer 2010;
102 (6) 981-986
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.